Table 2.
n (%) | ||
---|---|---|
Diseases 1 | 41 (36.0%) | |
Endocrinological and metabolic diseases * | 10 (8.8%) | |
Cardiovascular diseases (hypertension) | 1 (0.9%) | |
Respiratory diseases (asthma) | 6 (5.3%) | |
Immune diseases (allergy, psoriasis, atopy) | 7 (6.1%) | |
Spinal/medullary pathology | 6 (5.3%) | |
Miscellaneous ** | 13 (11.4%) | |
Medication intake 1 | 12 (10.5%) | |
Oral contraceptives | 4 (3.5%) | |
Thyroid hormone replacement therapy | 4 (3.5%) | |
Other medicines *** | 5 (4.4%) | |
Twin pregnancy | 4 (3.5%) | |
Problems in the last pregnancy 1 | 36 (31.6%) | |
Thyroid disorders | 17 (14.9%) | |
Preeclampsia | 2 (1.8%) | |
Gestational diabetes | 2 (1.8%) | |
Intrauterine fetal growth restriction | 6 (5.3%) | |
Intrauterine fetal death | 3 (2.6%) | |
Other problems **** | 11 (9.6%) |
1 The categories do not exclude each other. * Endocrinological and metabolic diseases included four cases of well-controlled hypothyroidism, four cases of subclinical thyroid disorders, and two cases of hypercholesterolemia. ** Miscellaneous included congenital amylase–sucrase deficiency, fatty liver, esophagitis, antiphospholipid syndrome, uveitis, migraines, polycystic ovary syndrome, cholesteatoma, venous insufficiency, recurrent urinary tract infections, human papillomavirus infection, and depression. *** Other medicines included antihistamines, antidepressants, proton-pump inhibitors, antivertiginous medications, and oral bronchodilators. **** Other problems included the threat of abortion, threat of premature birth, feto-fetal transfusion syndrome, chorioamnionitis, oligohydramnios, intrahepatic cholestasis, cytomegalovirus infection, bronchitis, and urinary tract infections.